1. Home
  2. ECG vs KNSA Comparison

ECG vs KNSA Comparison

Compare ECG & KNSA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ECG
  • KNSA
  • Stock Information
  • Founded
  • ECG 1995
  • KNSA 2015
  • Country
  • ECG United States
  • KNSA United Kingdom
  • Employees
  • ECG N/A
  • KNSA N/A
  • Industry
  • ECG
  • KNSA Biotechnology: Pharmaceutical Preparations
  • Sector
  • ECG
  • KNSA Health Care
  • Exchange
  • ECG NYSE
  • KNSA Nasdaq
  • Market Cap
  • ECG 2.1B
  • KNSA 1.9B
  • IPO Year
  • ECG N/A
  • KNSA 2018
  • Fundamental
  • Price
  • ECG $57.37
  • KNSA $27.39
  • Analyst Decision
  • ECG Buy
  • KNSA Strong Buy
  • Analyst Count
  • ECG 3
  • KNSA 5
  • Target Price
  • ECG $73.00
  • KNSA $38.80
  • AVG Volume (30 Days)
  • ECG 787.9K
  • KNSA 474.9K
  • Earning Date
  • ECG 05-13-2025
  • KNSA 07-22-2025
  • Dividend Yield
  • ECG N/A
  • KNSA N/A
  • EPS Growth
  • ECG 14.34
  • KNSA N/A
  • EPS
  • ECG 2.98
  • KNSA N/A
  • Revenue
  • ECG $3,050,625,000.00
  • KNSA $481,166,000.00
  • Revenue This Year
  • ECG $8.36
  • KNSA $37.21
  • Revenue Next Year
  • ECG $6.57
  • KNSA $5.32
  • P/E Ratio
  • ECG $19.44
  • KNSA N/A
  • Revenue Growth
  • ECG 11.77
  • KNSA 59.45
  • 52 Week Low
  • ECG $31.38
  • KNSA $17.38
  • 52 Week High
  • ECG $77.93
  • KNSA $28.56
  • Technical
  • Relative Strength Index (RSI)
  • ECG N/A
  • KNSA 63.27
  • Support Level
  • ECG N/A
  • KNSA $26.58
  • Resistance Level
  • ECG N/A
  • KNSA $27.90
  • Average True Range (ATR)
  • ECG 0.00
  • KNSA 0.99
  • MACD
  • ECG 0.00
  • KNSA -0.06
  • Stochastic Oscillator
  • ECG 0.00
  • KNSA 85.45

About ECG EVERUS CONSTRUCTION GROUP INC

Everus Construction Group Inc is a construction solutions provider, offering specialty contracting services to a diverse set of end markets across the U.S. It operates across two segments Electrical & Mechanical (E&M) and Transmission & Distribution (T&D), and delivers services through its subsidiaries. It generates the majority of revenue from the Electrical & Mechanical segment which offers a wide variety of specialty contracting services, including construction and maintenance of electrical and communication wiring, fire suppression systems, and mechanical piping and services, to customers in both the public and private sectors. Its T&D segment serves electric and natural gas utility customers, as well as customers in the transportation end market, in the West and Midwest regions.

About KNSA Kiniksa Pharmaceuticals Ltd.

Kiniksa Pharmaceuticals International PLC is a clinical-stage biopharmaceutical company focused on discovering, acquiring, developing, and commercializing therapeutic medicines for patients suffering from debilitating diseases. The company's clinical-stage product candidates include Rilonacept, abiprubart, and mavrilimumab.

Share on Social Networks: